gvtcx

NHS National Pharmaceuticals Transition 2020_2

NHS England Published 4 Aug 2020 Contracts Finder

key details

Value£7,190,000
Statuscomplete
Category (CPV) 33600000 +1 more
RegionNorth East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West
Deadline3 Sept 2020
Contract start1 Dec 2020
Contract end30 Jun 2022
Procedureopen
SME suitableYes
OCIDocds-b5fd17-7794ddce-62fc-4be4-bc35-be7b9eb80c66

Award

SupplierValueDateStatus
Please see list of awarded suppliers (including SME status) at t £7,190,000 12 Oct 2020 active

description

NHS National Pharmaceuticals Transition 2020_2

Offer reference number: CM/PHG/20/5618

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 38 months (19 months plus options to extend (at the Authority's sole discretion) for up to a further 19 months)

Potential periods of call-offs under the framework agreement

Transition Products:

LSNE 01/12/2020 to 30/09/2021 (10 months)

NWLN 01/12/2020 to 31/01/2022 (14 months)
CESW01/12/2020 to 30/06/2022 (19 months)

Hospital Only Products:

All Regions 01/12/2020 to 31/01/2022 (14 months)

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
2 Nov 2020 Award (award) · 85096a75-177b-45d8-9f75-716ea5dae4c7-390670

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.